EVALUATION OF THE EFFECT OF TOPICALLY APPLIED METHYLSULFONYLMETHANE AND THEIR COMBINATION WITH MINOXIDIL SOLUTION FOR IMPROVEMENT OF HAIR GROWTH IN MALE MICE

Wiad Lek. 2022;75(11 pt 2):2744-2751. doi: 10.36740/WLek202211206.

Abstract

Objective: The aim: The purpose of this research was to find out the effect of Methylsulfonylmethane in minimizing hair loss.

Patients and methods: Materials and methods: Twenty adult Wister Albino mice weighing 25-35g and aged 6-7 weeks were employed. Male mice's coat hairs on the dorsal skin were carefully clipped and then colored. Mice were randomly assigned into four groups, each with five animals: (1) Control group: Treated with D.W. (2), Minoxidil (5%) treated group (3), Methylsulfonylmethane (10%) treated group (4), Methylsulfonylmethane plus Minoxidil treated group.

Results: Results: We found that the tissue level of 8-isoprastanein the groups receiving medication are considerably lower than in the control (D.W.). We also discovered that the serum tissue vascular endothelial growth factor levels in the groups receiving medication are considerably greater than those in the control (D.W.) groups. On the other hand, we discovered that hair growth, hair follicle expansion and hair follicle number are much higher in the groups receiving medication than in the control groups.

Conclusion: Conclusions: We concluded that MSM, through its antioxidant and anti-inflammatory properties, dramatically reduces hair loss in male mice.

Keywords: 8-isoprostanes and VEGF; Methylsulfonylmethan; Minoxidil; hair loss.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Alopecia* / drug therapy
  • Animals
  • Male
  • Mice
  • Minoxidil* / pharmacology
  • Minoxidil* / therapeutic use
  • Vascular Endothelial Growth Factor A

Substances

  • dimethyl sulfone
  • Minoxidil
  • Vascular Endothelial Growth Factor A